FEBRUARY 11, 2025
Decreasing Postoperative Adverse Events and Waste Costs With Low-Dose Opioid And Ready-to-Administer (RTA) Medications
This Special Report reviews data evaluating the association of adverse outcomes and intraoperative opioid dose; describes data quantifying the amount and cost of drug waste based on multiple ready-to-administer (RTA) and vial sizes, highlighting the need for product size optimization; outlines the effect of drug waste on the health care system, patient, and environment; quantifies the holistic costs associated with drug waste; and proposes best practice recommendations to optimize product size to improve patient outcomes and reduce excess costs.
Download to read this article in PDF format:
Decreasing Postoperative Adverse Events and Waste Costs With Low-Dose Opioid And Ready-to-Administer (RTA) Medications
This article is in PDF format and it requires Adobe Reader.
If you do not have Adobe Reader installed on your computer then please download and install from the link below.
Download Adobe Reader
Please log in to post a comment